|Slideshows|September 30, 2022

In Case You Missed It: Psychiatric Times Psychedelics Supplement

Vol. 39, Issue 9 covers the latest in psychedelics research and development in psychiatry.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Psychedelic-Assisted Healing for System-Impacted People: A New Research and Policy Initiative

BySia Henry, JD

June 18th 2026

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

ByLeah Kuntz,AJ Cannon, MD

June 10th 2026

Research Frontiers in Ketamine and Esketamine for Treatment-Resistant Depression

ByMorgan Hardy, MD,William Li, MD

June 2nd 2026

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy

ByWilliam Li, MD,Morgan Hardy, MD

June 2nd 2026

Morning Rounds: March 25-31

ByJessica Walters

June 1st 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

In Case You Missed It: Psychiatric Times Psychedelics Supplement

Related Content

Psychedelic-Assisted Healing for System-Impacted People: A New Research and Policy Initiative

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Research Frontiers in Ketamine and Esketamine for Treatment-Resistant Depression

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy

Morning Rounds: March 25-31

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD

Transcranial Direct Current Stimulation to Enhance Brain Activity: Applicability for Schizophrenia

How Sleep Conditions Predict the Likelihood and Severity of Falls in Older Adults